Growth Inhibition and Apoptosis Induction of Human Umbilical Vein Endothelial
Yong-Hua Zhan,Xiao-Feng Huang,Xing-Bin Hu,Qun-Xing An,Zhi-Xin,Liu,Xian-Qing Zhang
2013-01-01
Abstract:Prostate cancer, one of the most common malignant tumors in the male reproductive system, causes the second most deaths of males. The mortality rate resulted from this cancer is only lower than that caused by lung cancer. Angiogenesis is an important process in growth, development, and in wound healing and granulation tissues. It is known that tumor expansion with formation of new blood vessels are related to metastasis (Weidner et al., 1991; Weidner et al., 1993; Holash et al., 1999; Hood et al., 2002). Therefore, the use of angiogenic inhibitors in order to reduce tumor metastasis is a promising method for treating tumors (O’Reilly et al., 1994; Konno et al., 1995; Zetter, 1998; Ebos et al., 2009; Pàez-Ribes et al., 2009). Prostate cancer is related to angiogenesis and vascular invasion and thus inhibition of angiogenesis can be used as a method to treat prostate cancers (Weidner et al., 1993; Bagley et al., 2011; Gyftopoulos et al., 2011; Assadian et al., 2012; Lynch et al., 2012; Pande et al., 2012; Pinto et al., 2012). We previously found that ApoG2, a gossypol derivative, inhibits proliferation of prostate cancer cells both in vitro and in vivo and induces their apoptosis and autophagy (Zhang et al., 2010a; Zhang et al., 2010b). Although it is reported that the anti-tumor effect of